By ThinkSabio #ThinkSabio Latest News
Iterum Therapeutics to discuss FDA approval of ORLYNVAH (Oral Sulopenem) for the treatment of uncomplicated urinary tract infections
Subscribe
for ThinkSabio Updates !
We'll keep you up to date about our Stocks, Sec Alerts , Trendings Stocks etc..